IXHL - Incannex to file for US testing of psychedelic drug for anxiety
2023-08-24 14:04:31 ET
More on Incannex Healthcare
- Incannex wins FDA OK to trial cannabinoid-based sleep apnea drug
- Incannex Healthcare to redomicile from Australia to US, list on Nasdaq
- Incannex rises 9% after Australia approval to begin phase 1 trial of anti-inflammatory drug
- Incannex adds over 19% with positive data for sleep apnea candidate
- Seeking Alpha’s Quant Rating on Incannex Healthcare
- Earnings data for Incannex Healthcare
For further details see:
Incannex to file for US testing of psychedelic drug for anxiety